Biocon Limited board approves QIP at ₹387.74 per share, with issue opening on 12 January 2026 and new oncology biosimilars announced.
S&P Global Ratings has upgraded the long-term issuer credit rating of Biocon Biologics Limited to 'BB+' from 'BB' and revised ...
Bengaluru: Biocon Limited has successfully concluded a Rs 4,150 crore (approximately USD 460 million) equity fundraise ...
Hosted on MSN
Biocon Limited’s credit ratings reaffirmed by CRISIL
The latest update is out from Biocon Limited ( (IN:BIOCON)). Biocon Limited has announced that CRISIL Ratings Limited has reaffirmed its credit ratings for the company’s bank facilities, maintaining a ...
PITTSBURGH, Dec. 6, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that it has entered into definitive agreements with Biocon Limited ("Biocon") for the sale of Viatris' equity stake ...
Hosted on MSN
Biocon shareholders clear capital expansion, preferential issue and higher investment limits at EGM
Biocon Limited ( (IN:BIOCON)) just unveiled an update. Biocon Limited reported the results of its Extraordinary General Meeting held on 31 December 2025 via video conferencing, where all resolutions ...
Biocon Limited has made a Qualified Institutions Placement of equity shares amounting to ₹4,150 crore (approximately $460 ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Get all latest & breaking news on Biocon Biologics Limited. Watch videos, top stories and articles on Biocon Biologics Limited at moneycontrol.com.
BRIDGEWATER, N.J. and BENGALURU, India, April 10, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results